Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Citi
Novartis
Chubb
Queensland Health
Teva
Healthtrust
Cerilliant
Fish and Richardson
Cantor Fitzgerald

Generated: February 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,859,504

« Back to Dashboard

Which drugs does patent 8,859,504 protect, and when does it expire?

Patent 8,859,504 protects NINLARO and is included in one NDA.

This patent has one hundred patent family members in thirty-five countries.
Summary for Patent: 8,859,504
Title:Boronate ester compounds and pharmaceutical compositions thereof
Abstract: The present invention provides novel compounds useful as proteasome inhibitors. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.
Inventor(s): Elliott; Eric L. (Watertown, MA), Ferdous; Abu J. (Nottingham, MD), Kaufman; Michael J. (Lexington, MA), Komar Lay; Sonja A. (Belmont, MA), Mazaik; Debra L. (Holliston, MA), McCubbin; Quentin J. (Belmont, MA), Nguyen; Phuong M. (Cambridge, MA), Palaniappan; Vaithianathan (Andover, MA), Skwierczynski; Raymond D. (Andover, MA), Truong; Nobel T. (Milford, MA), Varga; Csanad M. (Newton, MA), Zawaneh; Peter N. (Brookline, MA)
Assignee: Millennium Pharmaceuticals, Inc. (Cambridge, MA)
Application Number:13/667,164
Patent Claim Types:
see list of patent claims
Compound; Composition;

Drugs Protected by US Patent 8,859,504

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Millennium Pharms NINLARO ixazomib citrate CAPSULE;ORAL 208462-001 Nov 20, 2015 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Millennium Pharms NINLARO ixazomib citrate CAPSULE;ORAL 208462-002 Nov 20, 2015 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Millennium Pharms NINLARO ixazomib citrate CAPSULE;ORAL 208462-003 Nov 20, 2015 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 8,859,504

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
2,014,018,301 ➤ Try a Free Trial
9,175,018 Boronate ester compounds and pharmaceutical compositions thereof ➤ Try a Free Trial
2,015,307,523 ➤ Try a Free Trial
9,175,017 Boronate ester compounds and pharmaceutical compositions thereof ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,859,504

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China 103497232 ➤ Try a Free Trial
China 107253966 ➤ Try a Free Trial
China 107253975 ➤ Try a Free Trial
China 107266480 ➤ Try a Free Trial
China 107266482 ➤ Try a Free Trial
Colombia 6321289 ➤ Try a Free Trial
Costa Rica 11850 ➤ Try a Free Trial
Costa Rica 20160014 ➤ Try a Free Trial
Costa Rica 20160015 ➤ Try a Free Trial
Cyprus 1116435 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Mallinckrodt
Cipla
Argus Health
Covington
Chinese Patent Office
Baxter
Harvard Business School
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot